June 2021 • PharmaTimes Magazine • 4-5


Contents


News Review

Features

Meet some of the most promising young stars of healthcare communications, brightening the sector's future


2021 trends in global clinical trials


Now's the time to position the UK as a global leader in RNA treatment and vaccines


Dr Jorg Taubel reflects on 20 years in clinical research in the UK


The key regulatory considerations for cell and gene therapy trials


COVID-19 and the rapid rise of genetic sequencing


Analysis

How pharma can develop a sensitive
and intelligent engagement approach
for clinical teams


The reality of prescribing freedoms
in the UK


Should pharma companies consider protecting the shape of their products?


The sky is the limit when it comes to
the use of virtual therapies


How virtual and augmented reality technologies will support data insights in future


How big pharma can help to improve the UK's CBD market


A look at the market potential and need for a harmonised regulatory framework


SmartPeople

Senior vice president and head of Patient Centricity at Astellas, on the need for patient centricity to deliver value to both patients and business


Professor Saad Shakir reflects on the gap in public knowledge about routine drug safety and pharmacovigilance activity